Matches in SemOpenAlex for { <https://semopenalex.org/work/W2067349738> ?p ?o ?g. }
- W2067349738 endingPage "430" @default.
- W2067349738 startingPage "424" @default.
- W2067349738 abstract "Study objective Management of chemical weapon casualties includes the timely administration of antidotes without contamination of rescuers. Personal protective equipment makes intravenous access difficult but does not prevent intraosseous drug administration. We therefore measured the systemic bioavailability of antidotes for organophosphorus nerve agent and cyanide poisoning when administered by the intraosseous, intravenous, and intramuscular routes in a small study of Göttingen minipigs. Methods Animals were randomly allocated to sequentially receive atropine (0.12 mg/kg by rapid injection), pralidoxime (25 mg/kg by injection during 2 minutes), and hydroxocobalamin (75 mg/kg during 10 minutes) by the intravenous or intraosseous route, or atropine and pralidoxime by the intramuscular route. Plasma concentrations were measured for 6 hours to characterize the antidote concentration-time profiles for each route. Results Maximum plasma concentrations of atropine and pralidoxime occurred within 2 minutes when administered by the intraosseous route compared with 8 minutes by the intramuscular route. Maximum plasma hydroxocobalamin concentration occurred at the end of the infusion when administered by the intraosseous route. The mean area under the concentration-time curve by the intraosseous route was similar to the intravenous route for all 3 drugs and similar to the intramuscular route for atropine and pralidoxime. Conclusion This study showed rapid and substantial antidote bioavailability after intraosseous administration that appeared similar to that of the intravenous route. The intraosseous route of antidote administration should be considered when intravenous access is difficult. Management of chemical weapon casualties includes the timely administration of antidotes without contamination of rescuers. Personal protective equipment makes intravenous access difficult but does not prevent intraosseous drug administration. We therefore measured the systemic bioavailability of antidotes for organophosphorus nerve agent and cyanide poisoning when administered by the intraosseous, intravenous, and intramuscular routes in a small study of Göttingen minipigs. Animals were randomly allocated to sequentially receive atropine (0.12 mg/kg by rapid injection), pralidoxime (25 mg/kg by injection during 2 minutes), and hydroxocobalamin (75 mg/kg during 10 minutes) by the intravenous or intraosseous route, or atropine and pralidoxime by the intramuscular route. Plasma concentrations were measured for 6 hours to characterize the antidote concentration-time profiles for each route. Maximum plasma concentrations of atropine and pralidoxime occurred within 2 minutes when administered by the intraosseous route compared with 8 minutes by the intramuscular route. Maximum plasma hydroxocobalamin concentration occurred at the end of the infusion when administered by the intraosseous route. The mean area under the concentration-time curve by the intraosseous route was similar to the intravenous route for all 3 drugs and similar to the intramuscular route for atropine and pralidoxime. This study showed rapid and substantial antidote bioavailability after intraosseous administration that appeared similar to that of the intravenous route. The intraosseous route of antidote administration should be considered when intravenous access is difficult." @default.
- W2067349738 created "2016-06-24" @default.
- W2067349738 creator A5014131139 @default.
- W2067349738 creator A5015632339 @default.
- W2067349738 creator A5020317078 @default.
- W2067349738 creator A5043764325 @default.
- W2067349738 creator A5044504867 @default.
- W2067349738 creator A5058244440 @default.
- W2067349738 creator A5067116503 @default.
- W2067349738 creator A5075418149 @default.
- W2067349738 creator A5080168707 @default.
- W2067349738 date "2012-10-01" @default.
- W2067349738 modified "2023-10-16" @default.
- W2067349738 title "Rapid and Complete Bioavailability of Antidotes for Organophosphorus Nerve Agent and Cyanide Poisoning in Minipigs After Intraosseous Administration" @default.
- W2067349738 cites W1921340098 @default.
- W2067349738 cites W1974657483 @default.
- W2067349738 cites W1984233195 @default.
- W2067349738 cites W1984851569 @default.
- W2067349738 cites W1986791526 @default.
- W2067349738 cites W1999112091 @default.
- W2067349738 cites W2008549400 @default.
- W2067349738 cites W2018245560 @default.
- W2067349738 cites W2028540711 @default.
- W2067349738 cites W2045649004 @default.
- W2067349738 cites W2046085932 @default.
- W2067349738 cites W2056393602 @default.
- W2067349738 cites W2073176915 @default.
- W2067349738 cites W2074587982 @default.
- W2067349738 cites W2089429052 @default.
- W2067349738 cites W2091657400 @default.
- W2067349738 cites W2118896966 @default.
- W2067349738 cites W2119049639 @default.
- W2067349738 cites W2123063654 @default.
- W2067349738 cites W2129651656 @default.
- W2067349738 cites W2133612127 @default.
- W2067349738 cites W2133974408 @default.
- W2067349738 cites W2142941850 @default.
- W2067349738 cites W2155955102 @default.
- W2067349738 cites W2159721263 @default.
- W2067349738 cites W2160795579 @default.
- W2067349738 cites W2473314232 @default.
- W2067349738 cites W2594459672 @default.
- W2067349738 doi "https://doi.org/10.1016/j.annemergmed.2012.05.013" @default.
- W2067349738 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22738685" @default.
- W2067349738 hasPublicationYear "2012" @default.
- W2067349738 type Work @default.
- W2067349738 sameAs 2067349738 @default.
- W2067349738 citedByCount "24" @default.
- W2067349738 countsByYear W20673497382013 @default.
- W2067349738 countsByYear W20673497382014 @default.
- W2067349738 countsByYear W20673497382015 @default.
- W2067349738 countsByYear W20673497382016 @default.
- W2067349738 countsByYear W20673497382017 @default.
- W2067349738 countsByYear W20673497382018 @default.
- W2067349738 countsByYear W20673497382019 @default.
- W2067349738 countsByYear W20673497382020 @default.
- W2067349738 countsByYear W20673497382021 @default.
- W2067349738 crossrefType "journal-article" @default.
- W2067349738 hasAuthorship W2067349738A5014131139 @default.
- W2067349738 hasAuthorship W2067349738A5015632339 @default.
- W2067349738 hasAuthorship W2067349738A5020317078 @default.
- W2067349738 hasAuthorship W2067349738A5043764325 @default.
- W2067349738 hasAuthorship W2067349738A5044504867 @default.
- W2067349738 hasAuthorship W2067349738A5058244440 @default.
- W2067349738 hasAuthorship W2067349738A5067116503 @default.
- W2067349738 hasAuthorship W2067349738A5075418149 @default.
- W2067349738 hasAuthorship W2067349738A5080168707 @default.
- W2067349738 hasConcept C126322002 @default.
- W2067349738 hasConcept C161176658 @default.
- W2067349738 hasConcept C179104552 @default.
- W2067349738 hasConcept C181199279 @default.
- W2067349738 hasConcept C181389837 @default.
- W2067349738 hasConcept C185592680 @default.
- W2067349738 hasConcept C2775859210 @default.
- W2067349738 hasConcept C2776093070 @default.
- W2067349738 hasConcept C2776291583 @default.
- W2067349738 hasConcept C2776327929 @default.
- W2067349738 hasConcept C2776588719 @default.
- W2067349738 hasConcept C2776619502 @default.
- W2067349738 hasConcept C2778455166 @default.
- W2067349738 hasConcept C2778706303 @default.
- W2067349738 hasConcept C2778816929 @default.
- W2067349738 hasConcept C2779365888 @default.
- W2067349738 hasConcept C2779750884 @default.
- W2067349738 hasConcept C2780506445 @default.
- W2067349738 hasConcept C2780820201 @default.
- W2067349738 hasConcept C2780829489 @default.
- W2067349738 hasConcept C2911027401 @default.
- W2067349738 hasConcept C29730261 @default.
- W2067349738 hasConcept C42219234 @default.
- W2067349738 hasConcept C508975757 @default.
- W2067349738 hasConcept C55493867 @default.
- W2067349738 hasConcept C6557445 @default.
- W2067349738 hasConcept C71924100 @default.
- W2067349738 hasConcept C86803240 @default.
- W2067349738 hasConcept C98274493 @default.
- W2067349738 hasConceptScore W2067349738C126322002 @default.
- W2067349738 hasConceptScore W2067349738C161176658 @default.